» Articles » PMID: 25516095

The Extracellular N-terminal Domain of G-protein Coupled Receptor 83 Regulates Signaling Properties and is an Intramolecular Inverse Agonist

Overview
Journal BMC Res Notes
Publisher Biomed Central
Date 2014 Dec 18
PMID 25516095
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Recently, the orphan G-protein coupled receptor 83 (GPR83) was identified as a new participant in body weight regulation. This receptor is highly expressed in the hypothalamic arcuate nucleus and is regulated in response to nutrient availability. Gpr83 knock-out mice are protected from diet-induced obesity. Moreover, in a previous study, we designed and characterized several artificial constitutively activating mutations (CAMs) in GPR83. A particular CAM was located in the extracellular N-terminal domain (eNDo) that is highly conserved among GPR83 orthologs. This suggests the contribution of this receptor part into regulation of signaling, which needed a more detailed investigation.

Findings: In this present study, therefore, we further explored the role of the eNDo in regulating GPR83-signaling and demonstrate a proof-of-principle approach in that deletion mutants are characterized by a strong increase in basal Gq/11-mediated signaling, whilst none of the additionally characterized signaling pathways (Gs, Gi, G12/13) were activated by the N-terminal deletion variants. Of note, we detected basal GPR83 MAPK-activity of the wild type receptor, which was not increased in the deletion variants.

Conclusions: Finally, the extracellular portion of GPR83 has a strong regulatory function on this receptor. A suppressive - inverse agonistic - effect of the eNDo on GPR83 signaling activity is demonstrated here, which also suggests a putative link between extracellular receptor activation and proteolytic cleavage. These new insights highlight important aspects of GPR83-regulation and might open options in the development of tools to modulate GPR83-signaling.

Citing Articles

Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation.

Mack S, Gomes I, Devi L ACS Chem Neurosci. 2019; 10(4):1884-1891.

PMID: 30726666 PMC: 6996248. DOI: 10.1021/acschemneuro.8b00559.


Prediction and validation of the structural features of Ov58GPCR, an immunogenic determinant of Onchocerca volvulus.

Shey R, Ghogomu S, Njume F, Gainkam L, Poelvoorde P, Mutesa L PLoS One. 2018; 13(9):e0202915.

PMID: 30256790 PMC: 6157839. DOI: 10.1371/journal.pone.0202915.


Orphan neuropeptides and receptors: Novel therapeutic targets.

Fricker L, Devi L Pharmacol Ther. 2017; 185:26-33.

PMID: 29174650 PMC: 5899030. DOI: 10.1016/j.pharmthera.2017.11.006.


Insights into Basal Signaling Regulation, Oligomerization, and Structural Organization of the Human G-Protein Coupled Receptor 83.

Muller A, Berkmann J, Scheerer P, Biebermann H, Kleinau G PLoS One. 2016; 11(12):e0168260.

PMID: 27936173 PMC: 5148169. DOI: 10.1371/journal.pone.0168260.


Identification of GPR83 as the receptor for the neuroendocrine peptide PEN.

Gomes I, Bobeck E, Margolis E, Gupta A, Sierra S, Fakira A Sci Signal. 2016; 9(425):ra43.

PMID: 27117253 PMC: 5147544. DOI: 10.1126/scisignal.aad0694.

References
1.
Zhang M, Sugawa H, Kosugi S, Mori T . Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Commun. 1995; 211(1):205-10. DOI: 10.1006/bbrc.1995.1797. View

2.
Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont J . The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem. 1994; 269(19):13733-5. View

3.
Van Sande J, Massart C, Costagliola S, Allgeier A, Cetani F, Vassart G . Specific activation of the thyrotropin receptor by trypsin. Mol Cell Endocrinol. 1996; 119(2):161-8. DOI: 10.1016/0303-7207(96)03804-x. View

4.
Mifune M, Ohtsu H, Suzuki H, Nakashima H, Brailoiu E, Dun N . G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor. J Biol Chem. 2005; 280(28):26592-9. DOI: 10.1074/jbc.M502906200. View

5.
Schwartz T, Frimurer T, Holst B, Rosenkilde M, Elling C . Molecular mechanism of 7TM receptor activation--a global toggle switch model. Annu Rev Pharmacol Toxicol. 2006; 46:481-519. DOI: 10.1146/annurev.pharmtox.46.120604.141218. View